Apolipoprotein B (ApoB)
A direct count of the atherogenic particles that cause heart disease. Because every LDL, VLDL and Lp(a) particle carries exactly one ApoB, it measures cardiovascular risk more precisely than LDL cholesterol — especially when triglycerides are high.
What it measures
ApoB is the structural protein wrapped around every particle that can drive atherosclerosis — LDL, VLDL, IDL and Lp(a). Crucially there is exactly one ApoB molecule per particle, so the ApoB number is a direct headcount of how many artery-damaging particles are circulating. Standard LDL-cholesterol measures the cholesterol inside those particles, which can mislead: two people with the same LDL-C can carry very different particle numbers, particularly when triglycerides are raised or particles are small and dense. In that discordance, ApoB is the better predictor of heart attack and stroke risk, which is why lipidology increasingly treats to an ApoB target.
What a high value can mean
- Elevated atherogenic particle burden — the core meaning; higher ApoB = more particles = higher cardiovascular risk, even if LDL-C looks acceptable.
- Familial hypercholesterolaemia — genetically very high.
- Insulin resistance / type 2 diabetes / metabolic syndrome — small-dense-LDL pattern raises particle count out of proportion to LDL-C.
- High saturated-fat diet, hypothyroidism, nephrotic syndrome, cholestasis.
- Discordance (high ApoB, 'normal' LDL-C) — the most valuable finding; risk is underestimated by LDL-C alone.
What a low value can mean
- Low cardiovascular risk — favourable.
- Effective statin / ezetimibe / PCSK9 therapy — a treatment goal.
- Very low levels — occasionally hyperthyroidism, malnutrition, or the rare genetic hypobetalipoproteinaemia.
When to discuss with a doctor
ApoB is most useful when standard lipids are ambiguous — high triglycerides, diabetes, metabolic syndrome, or a strong family history despite an 'okay' LDL-C. A high ApoB with a normal LDL-C means your risk is being underestimated and is a reason to intensify lifestyle and, with your doctor, consider lipid-lowering therapy to an ApoB target (broadly <90, <80, or <65 mg/dL by risk tier). It is also a clean way to confirm treatment is working. Mediora.AI shows ApoB alongside your full lipid panel and flags LDL-C/ApoB discordance; the treatment decision and cardiovascular risk scoring belong with your GP or cardiologist.